EYPT
Price
$10.07
Change
-$0.51 (-4.82%)
Updated
Aug 7 closing price
Capitalization
692.93M
82 days until earnings call
TCRX
Price
$1.65
Change
-$0.10 (-5.71%)
Updated
Aug 7 closing price
Capitalization
93.37M
5 days until earnings call
Interact to see
Advertisement

EYPT vs TCRX

Header iconEYPT vs TCRX Comparison
Open Charts EYPT vs TCRXBanner chart's image
EyePoint Pharmaceuticals
Price$10.07
Change-$0.51 (-4.82%)
Volume$785.06K
Capitalization692.93M
TScan Therapeutics
Price$1.65
Change-$0.10 (-5.71%)
Volume$264.02K
Capitalization93.37M
EYPT vs TCRX Comparison Chart in %
Loading...
EYPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TCRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
EYPT vs. TCRX commentary
Aug 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EYPT is a Hold and TCRX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 08, 2025
Stock price -- (EYPT: $10.07 vs. TCRX: $1.65)
Brand notoriety: EYPT and TCRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: EYPT: 107% vs. TCRX: 60%
Market capitalization -- EYPT: $692.93M vs. TCRX: $93.37M
EYPT [@Biotechnology] is valued at $692.93M. TCRX’s [@Biotechnology] market capitalization is $93.37M. The market cap for tickers in the [@Biotechnology] industry ranges from $199.59B to $0. The average market capitalization across the [@Biotechnology] industry is $2.29B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EYPT’s FA Score shows that 1 FA rating(s) are green whileTCRX’s FA Score has 1 green FA rating(s).

  • EYPT’s FA Score: 1 green, 4 red.
  • TCRX’s FA Score: 1 green, 4 red.
According to our system of comparison, EYPT is a better buy in the long-term than TCRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

EYPT’s TA Score shows that 3 TA indicator(s) are bullish while TCRX’s TA Score has 5 bullish TA indicator(s).

  • EYPT’s TA Score: 3 bullish, 5 bearish.
  • TCRX’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, TCRX is a better buy in the short-term than EYPT.

Price Growth

EYPT (@Biotechnology) experienced а +2.55% price change this week, while TCRX (@Biotechnology) price change was -8.84% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.18%. For the same industry, the average monthly price growth was +8.39%, and the average quarterly price growth was +12.02%.

Reported Earning Dates

EYPT is expected to report earnings on Oct 29, 2025.

TCRX is expected to report earnings on Aug 13, 2025.

Industries' Descriptions

@Biotechnology (+1.18% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
EYPT($693M) has a higher market cap than TCRX($93.4M). EYPT YTD gains are higher at: 35.168 vs. TCRX (-45.724). TCRX has higher annual earnings (EBITDA): -124.58M vs. EYPT (-144.55M). EYPT has more cash in the bank: 318M vs. TCRX (252M). EYPT has less debt than TCRX: EYPT (24.1M) vs TCRX (97M). EYPT has higher revenues than TCRX: EYPT (56M) vs TCRX (4.42M).
EYPTTCRXEYPT / TCRX
Capitalization693M93.4M742%
EBITDA-144.55M-124.58M116%
Gain YTD35.168-45.724-77%
P/E RatioN/AN/A-
Revenue56M4.42M1,267%
Total Cash318M252M126%
Total Debt24.1M97M25%
FUNDAMENTALS RATINGS
EYPT: Fundamental Ratings
EYPT
OUTLOOK RATING
1..100
62
VALUATION
overvalued / fair valued / undervalued
1..100
60
Fair valued
PROFIT vs RISK RATING
1..100
88
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
38
P/E GROWTH RATING
1..100
18
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
EYPTTCRX
RSI
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
85%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
84%
Bullish Trend 1 day ago
80%
Momentum
ODDS (%)
Bearish Trend 1 day ago
82%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
88%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
84%
Bearish Trend 1 day ago
89%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
83%
Bearish Trend 1 day ago
89%
Advances
ODDS (%)
Bullish Trend 3 days ago
86%
Bullish Trend 3 days ago
81%
Declines
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 7 days ago
90%
BollingerBands
ODDS (%)
N/A
Bullish Trend 1 day ago
87%
Aroon
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 1 day ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
EYPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TCRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
IVIFX21.070.22
+1.06%
Macquarie International Core Eq C
COMVX4.36N/A
N/A
Comstock Capital Value AAA
WHGIX12.25N/A
N/A
Westwood Income Opportunity Instl
JLCWX73.39N/A
N/A
JHancock Fundamental Large Cap Core R6
TVSVX18.91N/A
N/A
Third Avenue Small Cap Value Investor

TCRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, TCRX has been loosely correlated with MGNX. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if TCRX jumps, then MGNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TCRX
1D Price
Change %
TCRX100%
-5.71%
MGNX - TCRX
46%
Loosely correlated
N/A
FATE - TCRX
44%
Loosely correlated
-5.63%
ABOS - TCRX
42%
Loosely correlated
+4.41%
CRBU - TCRX
41%
Loosely correlated
-3.72%
EYPT - TCRX
41%
Loosely correlated
-4.82%
More